Atlas Trials

Carcinoma in Situ

22 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Carcinoma in Situ

RecordFirmDate
Handheld Ultrasound Device to Triage Women With a Positive Clinical Breast Examination by Trained Non-radiologists (NCT06056843)International Agency for Research on Cancer2022-05-09
A Study of Intravesical Enfortumab Vedotin For Treatment of Patients With Non-muscle Invasive Bladder Cancer (NMIBC) (NCT05014139)Astellas Pharma Global Development, Inc.2021-12-07
PDT Plus Vitamin D3 for Anal Dysplasia (NCT02698293)Abramson Cancer Center at Penn Medicine2019-12-01
Implementing a Virtual Tobacco Treatment for Cancer Patients in Community Oncology Practices (NCT03808818)ECOG-ACRIN Cancer Research Group2019-08-01
Early Detection of High Grade Ovarian Cancer Using Uterine Lavage EHUD Study and Duplex Sequencing (NCT04823871)Paul Speiser, Prof.MD,2018-11-01
Effects of Avmacol® in the Oral Mucosa of Patients Following Curative Treatment for Tobacco-related Head and Neck Cancer (NCT03268993)University of Pittsburgh2018-07-27
Web-Based Physical Activity Intervention in Improving Long Term Health in Children and Adolescents With Cancer (NCT03223753)Children's Oncology Group2017-11-29
Broccoli Sprout Extract in Preventing Recurrence in Patients With Tobacco-Related Head and Neck Squamous Cell Cancer (NCT03182959)University of Arizona2017-04-24
E7 TCR T Cells for Human Papillomavirus-Associated Cancers (NCT02858310)National Cancer Institute (NCI)2017-01-27
Project: Every Child for Younger Patients With Cancer (NCT02402244)Children's Oncology Group2015-11-03
Efficacy Study of Recombinant Adenovirus for Non Muscle Invasive Bladder Cancer (NCT01438112)CG Oncology, Inc.2014-03-01
Localization of Nonpalpable Breast Lesions (NCT01901991)Rigshospitalet, Denmark2014-01-01
Lavage of the Uterine Cavity for the Diagnosis of Serous Tubal Intraepithelial Carcinoma (NCT02039388)Medical University of Vienna2013-11-01
Study With TMX-101 in Patients With Carcinoma In Situ (CIS) Bladder Cancer (NCT01731652)Telormedix SA2013-02-01
Value of Narrow Band Imaging (NBI) Endoscopy in the Early Diagnosis of Laryngeal Cancer and Precancerous Lesions (NCT02217358)University Hospital Ostrava2012-02-01
Multi-center Study to Evaluate the Efficacy and Safety of Maintenance Therapy With Valrubicin Versus no Maintenance, in Subjects Treated With Valrubicin Induction for Carcinoma in Situ (CIS) of the Bladder (NCT01310803)Endo USA Inc., a Keenova Therapeutics Company2011-05-01
Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer (NCT01200992)Bioniche Life Sciences Inc.2010-11-01
Intravesical AD 32 (Valrubicin) in Patients With Carcinoma in Situ (CIS) of the Bladder Who Have Failed or Have Recurrence Following Treatment With Bacillus Calmette-guerin (BCG) (NCT01316874)Endo USA Inc., a Keenova Therapeutics Company1993-11-01

Track Carcinoma in Situ automatically

Every clearance here is in the API, with alerts when new ones post.